Alexion Pharmaceuticals
Industry: Biotechnology
Employees: 500-999
Revenue: $386M+
Headquarters: Cheshire, CT

Overview

Alexion Pharmaceuticals is the original developer and distributor of Soliris, a drug used in treating the ultra-rare disorders Hemolytic-uremic syndrome and Paroxysmal nocturnal hemoglobinuria (PNH). In a recent study Soliris was noted for its effectiveness in altering the natural course of PNH (less symptoms, fewer complications).

Open Jobs (86)

See More Jobs →
Feedback Loading...